"We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
Community organizing
Harm reduction
Housing insecurity
Substance use
Journal
SSM. Qualitative research in health
ISSN: 2667-3215
Titre abrégé: SSM Qual Res Health
Pays: England
ID NLM: 9918300877606676
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
14
05
2021
revised:
24
09
2021
accepted:
26
09
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
7
12
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic and ensuing service delivery interruptions had serious impacts on people who use drugs (PWUD) and people experiencing homelessness, including instability in the drug supply, decreased access to substance use disorder (SUD) treatment and harm reduction supplies, increased substance use and relapse due to stress and isolation, inability to properly isolate and quarantine without stable housing, and risk of COVID-19 spread in congregate living spaces. At the same time, many have noted a potential opportunity for rapid change in health, housing, and drug policy despite previous stagnation-referred to as a "punctuated equilibrium" by Baumgartner and Jones-in response to the pandemic. The pandemic forced some important policy interventions in the United States at both national and local levels, including eviction moratoriums and loosening of drug policy related to substance use treatment. However, to what extent some of these changes will be sustained past the current COVID-19 crisis is still unclear, as is how drug and housing related policy shifts have impacted the work of frontline overdose prevention, substance use treatment, and homelessness advocacy workers. In this qualitative study, we used semi-structured interviews to assess how Philadelphia's harm reduction advocates, community organizers, and SUD treatment clinicians have responded to the overdose and homelessness crises during COVID-19, and how they predict the pandemic and ensuing policy changes will impact the future of overdose prevention, harm reduction efforts, and homelessness advocacy. We interviewed 30 eligible participants during July and August 2020. The analysis of these data yielded three themes: 1/"None of it should be new to anybody": COVID-era issues impacting PWUD and people experiencing homelessness are extensions of existing problems; 2/"An opportunity to actually benefit in some way from this crisis": Possibility for innovation and improved care for PWUD and people experiencing homelessness; and 3/"Nothing we've tried has worked, so we have to be uncomfortable and creative": The uncertain path forward. Despite the many barriers that participants faced to promoting the health and well-being of marginalized communities during the pandemic, they also believed that the pandemic presented an important opportunity for positive policy change that has the potential to promote drug user health into the future, including a continuation of loosened federal restrictions on substance use disorder treatment, legalization of safe consumption spaces, safe supply of substances, and progressive, creative housing solutions.
Identifiants
pubmed: 34870265
doi: 10.1016/j.ssmqr.2021.100013
pii: S2667-3215(21)00013-5
pmc: PMC8485140
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100013Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Drug Alcohol Rev. 2020 May;39(4):297-300
pubmed: 32445265
Transl Res. 2021 Aug;234:159-173
pubmed: 33746108
Int J Drug Policy. 2021 Apr;90:103076
pubmed: 33321286
J Addict Med. 2020 Jul/Aug;14(4):e6-e7
pubmed: 32404651
Int J Drug Policy. 2020 Sep;83:102901
pubmed: 32807624
Am J Public Health. 2021 Apr;111(4):667-671
pubmed: 33600254
J Hum Lact. 2019 May;35(2):220-222
pubmed: 30849272
Am J Public Health. 2020 Apr;110(4):505-507
pubmed: 32159987
Int J Drug Policy. 2021 Jul;93:102905
pubmed: 32811685
Int J Drug Policy. 2021 Aug;94:103199
pubmed: 33765515
J Urban Health. 2021 Aug;98(4):532-537
pubmed: 33710493
Lancet Public Health. 2020 Apr;5(4):e186-e187
pubmed: 32171054
J Subst Abuse Treat. 2021 Apr;123:108258
pubmed: 33358617
Int J Drug Policy. 2020 Sep;83:102821
pubmed: 32591222
JAMA Psychiatry. 2021 May 1;78(5):562-564
pubmed: 33270086
J Subst Abuse Treat. 2021 Apr;123:108276
pubmed: 33612201
Soc Sci Med. 2019 Mar;225:60-68
pubmed: 30798157
Nat Med. 2020 Jun;26(6):819-820
pubmed: 32555514
JAMA Netw Open. 2021 Jan 4;4(1):e2034878
pubmed: 33475751
Ann Intern Med. 2020 Jul 7;173(1):61-62
pubmed: 32240293
Soc Sci Med. 2021 Feb;270:113631
pubmed: 33418149
Am J Public Health. 2018 Feb;108(2):182-186
pubmed: 29267060
Harm Reduct J. 2017 May 18;14(1):28
pubmed: 28521829
Am J Community Psychol. 2009 Dec;44(3-4):213-20
pubmed: 19777338